BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 20418055)

  • 21. Magnetic resonance imaging and response to cardiac resynchronization therapy: relative merits of left ventricular dyssynchrony and scar tissue.
    Marsan NA; Westenberg JJ; Ypenburg C; van Bommel RJ; Roes S; Delgado V; Tops LF; van der Geest RJ; Boersma E; de Roos A; Schalij MJ; Bax JJ
    Eur Heart J; 2009 Oct; 30(19):2360-7. PubMed ID: 19578165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reverse remodelling induces progressive ventricular resynchronization after cardiac resynchronization therapy 'from vicious to virtuous cycle'.
    Matsumoto K; Tanaka H; Okajima K; Hayashi T; Kajiya T; Sugiyama D; Kawai H; Hirata K
    Eur J Echocardiogr; 2011 Oct; 12(10):782-9. PubMed ID: 21865225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanism of improvement in mitral regurgitation after cardiac resynchronization therapy.
    Ypenburg C; Lancellotti P; Tops LF; Boersma E; Bleeker GB; Holman ER; Thomas JD; Schalij MJ; Piérard LA; Bax JJ
    Eur Heart J; 2008 Mar; 29(6):757-65. PubMed ID: 18305084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Usefulness of QRS duration to predict response to cardiac resynchronization therapy in patients with end-stage heart failure.
    Mollema SA; Bleeker GB; van der Wall EE; Schalij MJ; Bax JJ
    Am J Cardiol; 2007 Dec; 100(11):1665-70. PubMed ID: 18036366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of LOw-dose DObutamine stress-echocardiography to predict cardiac resynchronization therapy response (LODO-CRT) multicenter prospective study: design and rationale.
    Muto C; Gasparini M; Iacopino S; Peraldo C; Curnis A; Sassone B; Diotallevi P; Davinelli M; Valsecchi S; Tuccillo B
    Am Heart J; 2008 Oct; 156(4):656-61. PubMed ID: 18926147
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toward understanding response to cardiac resynchronization therapy: left ventricular dyssynchrony is only one of multiple mechanisms.
    Parsai C; Bijnens B; Sutherland GR; Baltabaeva A; Claus P; Marciniak M; Paul V; Scheffer M; Donal E; Derumeaux G; Anderson L
    Eur Heart J; 2009 Apr; 30(8):940-9. PubMed ID: 19004844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exercise stress echocardiography is superior to rest echocardiography in predicting left ventricular reverse remodelling and functional improvement after cardiac resynchronization therapy.
    Rocchi G; Bertini M; Biffi M; Ziacchi M; Biagini E; Gallelli I; Martignani C; Cervi E; Ferlito M; Rapezzi C; Branzi A; Boriani G
    Eur Heart J; 2009 Jan; 30(1):89-97. PubMed ID: 18987095
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The influence of myocardial scar and dyssynchrony on reverse remodeling in cardiac resynchronization therapy.
    Jansen AH; Bracke F; van Dantzig JM; Peels KH; Post JC; van den Bosch HC; van Gelder B; Meijer A; Korsten HH; de Vries J; van Hemel NM
    Eur J Echocardiogr; 2008 Jul; 9(4):483-8. PubMed ID: 17826355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between improvement in left ventricular dyssynchrony and contractile function and clinical outcome with cardiac resynchronization therapy: the MADIT-CRT trial.
    Pouleur AC; Knappe D; Shah AM; Uno H; Bourgoun M; Foster E; McNitt S; Hall WJ; Zareba W; Goldenberg I; Moss AJ; Pfeffer MA; Solomon SD;
    Eur Heart J; 2011 Jul; 32(14):1720-9. PubMed ID: 21609974
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiac resynchronization therapy in patients with systolic left ventricular dysfunction and symptoms of mild heart failure secondary to ischemic or nonischemic cardiomyopathy.
    Bleeker GB; Schalij MJ; Holman ER; Steendijk P; van der Wall EE; Bax JJ
    Am J Cardiol; 2006 Jul; 98(2):230-5. PubMed ID: 16828599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of cardiac resynchronization therapy on the mechanisms underlying functional mitral regurgitation in congestive heart failure.
    Porciani MC; Macioce R; Demarchi G; Chiostri M; Musilli N; Cappelli F; Lilli A; Ricciardi G; Padeletti L
    Eur J Echocardiogr; 2006 Jan; 7(1):31-9. PubMed ID: 16378918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Are the extent, location, and score of segmental wall motion abnormalities related to cardiac resynchronization therapy response?
    Shen X; Aronow WS; Nair CK; Holmberg MJ; Hee T; Maciejewski S; Esterbrooks DJ
    Echocardiography; 2009 Nov; 26(10):1136-45. PubMed ID: 19725853
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sustained reverse left ventricular structural remodeling with cardiac resynchronization at one year is a function of etiology: quantitative Doppler echocardiographic evidence from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE).
    Sutton MG; Plappert T; Hilpisch KE; Abraham WT; Hayes DL; Chinchoy E
    Circulation; 2006 Jan; 113(2):266-72. PubMed ID: 16401777
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early and late effects of cardiac resynchronization therapy on exercise-induced mitral regurgitation: relationship with left ventricular dyssynchrony, remodelling and cardiopulmonary performance.
    Madaric J; Vanderheyden M; Van Laethem C; Verhamme K; Feys A; Goethals M; Verstreken S; Geelen P; Penicka M; De Bruyne B; Bartunek J
    Eur Heart J; 2007 Sep; 28(17):2134-41. PubMed ID: 17504802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiac resynchronization therapy in patients with a narrow QRS complex.
    Bleeker GB; Holman ER; Steendijk P; Boersma E; van der Wall EE; Schalij MJ; Bax JJ
    J Am Coll Cardiol; 2006 Dec; 48(11):2243-50. PubMed ID: 17161254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiarrhythmic effect of reverse ventricular remodeling induced by cardiac resynchronization therapy: the InSync ICD (Implantable Cardioverter-Defibrillator) Italian Registry.
    Di Biase L; Gasparini M; Lunati M; Santini M; Landolina M; Boriani G; Curnis A; Bocchiardo M; Vincenti A; Denaro A; Valsecchi S; Natale A; Padeletti L;
    J Am Coll Cardiol; 2008 Oct; 52(18):1442-9. PubMed ID: 19017510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined dyssynchrony and scar imaging with cardiac magnetic resonance imaging predicts clinical response and long-term prognosis following cardiac resynchronization therapy.
    Taylor AJ; Elsik M; Broughton A; Cherayath J; Leet A; Wong C; Iles L; Butler M; Pfluger H
    Europace; 2010 May; 12(5):708-13. PubMed ID: 20190262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implantable cardioverter-defibrillator patients who are upgraded and respond to cardiac resynchronization therapy have less ventricular arrhythmias compared with nonresponders.
    Thijssen J; Borleffs CJ; Delgado V; van Rees JB; Mooyaart EA; van Bommel RJ; van Erven L; Boersma E; Bax JJ; Schalij MJ
    J Am Coll Cardiol; 2011 Nov; 58(22):2282-9. PubMed ID: 22093504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of mitral regurgitation and myocardial viability on left ventricular reverse remodeling after cardiac resynchronization therapy in patients with ischemic cardiomyopathy.
    Sénéchal M; Lancellotti P; Magne J; Garceau P; Champagne J; Philippon F; O'Hara G; Moonen M; Dubois M
    Am J Cardiol; 2010 Jul; 106(1):31-7. PubMed ID: 20609643
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characteristics of heart failure patients associated with good and poor response to cardiac resynchronization therapy: a PROSPECT (Predictors of Response to CRT) sub-analysis.
    van Bommel RJ; Bax JJ; Abraham WT; Chung ES; Pires LA; Tavazzi L; Zimetbaum PJ; Gerritse B; Kristiansen N; Ghio S
    Eur Heart J; 2009 Oct; 30(20):2470-7. PubMed ID: 19717847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.